Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This is a single center, open prospective study to evaluate the effectiveness of quetiapine
monotherapy in the maintenance treatment of adolescent patients with a bipolar spectrum
disorder (bipolar I and bipolar II disorders, cyclothymia, and bipolar disorder not otherwise
specified [bipolar NOS]) for a minimum of 48 weeks. Patients will be screened (enrolment
phase) either when already stabilized or during an acute episode of mania/hypomania or
depression.